Is Nurix Therapeutics Inc (NRIX) Stock at the Top of the Biotechnology Industry?

A rating of 55 puts Nurix Therapeutics Inc (NRIX) near the middle of the Biotechnology industry according to InvestorsObserver. Nurix Therapeutics Inc's score of 55 means it scores higher than 55% of stocks in the industry. Nurix Therapeutics Inc also received an overall rating of 45, putting it above 45% of all stocks. Biotechnology is ranked 55 out of the 148 industries.

NRIX has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on NRIX!

See Full NRIX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 45 would rank higher than 45 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Nurix Therapeutics Inc Stock Today?

Nurix Therapeutics Inc (NRIX) stock is trading at $6.30 as of 12:48 PM on Friday, Nov 3, an increase of $0.75, or 13.41% from the previous closing price of $5.56. The stock has traded between $5.70 and $6.67 so far today. Volume today is below average. So far 352,580 shares have traded compared to average volume of 577,365 shares. Click Here to get the full Stock Report for Nurix Therapeutics Inc stock.